BioDelivery Sciences logo
BioDelivery Sciences to Present at the William Blair 2018 Growth Stock Conference
June 01, 2018 08:00 ET | BioDelivery Sciences International, Inc.
RALEIGH, N.C., June 01, 2018 (GLOBE NEWSWIRE) -- BioDelivery Sciences International, Inc., (NASDAQ:BDSI), a leading specialty pharmaceutical company in the field of pain management and addiction...
BioDelivery Sciences logo
BioDelivery Sciences to Present at the Jefferies 2018 Global Healthcare Conference
May 23, 2018 08:00 ET | BioDelivery Sciences International, Inc.
RALEIGH, N.C., May 23, 2018 (GLOBE NEWSWIRE) -- BioDelivery Sciences International, Inc., (NASDAQ:BDSI), a specialty pharmaceutical company with a focus in pain management and addiction medicine,...
BioDelivery Sciences logo
BioDelivery Sciences Announces Closing of $50 Million Equity Financing and Appointment of Peter Greenleaf as Chairman of the Board
May 22, 2018 08:29 ET | BioDelivery Sciences International, Inc.
RALEIGH, N.C., May 22, 2018 (GLOBE NEWSWIRE) -- BioDelivery Sciences International, Inc. (NASDAQ:BDSI) today announced it has closed its previously announced $50 million registered direct offering...
BioDelivery Sciences logo
BioDelivery Sciences Announces Agreement with Broadfin Capital on Comprehensive Plan to Strengthen Business
May 17, 2018 08:01 ET | BioDelivery Sciences International, Inc.
$50 Million Equity Financing Led By Broadfin Announced Separately Today Three New Independent Directors Selected by Broadfin Added To Board; Four Current Independent Directors Retiring Amends...
Endonovo Therapeutics Signs Distribution Agreement with Plagens Medical Consultants for its Pain Relief Electroceutical™ SofPulse®
May 09, 2018 13:30 ET | Endonovo Therapeutics, Inc.
LOS ANGELES, CA, May 09, 2018 (GLOBE NEWSWIRE) --  Endonovo Therapeutics, Inc. (OTCQB: ENDV) ("Endonovo" or the "Company"), a commercial-stage developer of Electroceutical™ Therapies, today...
clri.jpg
Cleartronic, Inc. (CLRI) Subsidiary VoiceInterop Signs Definitive Agreement Acquiring the Assets of CanniPlus Global, Inc.
April 24, 2018 09:00 ET | Cleartronic, Inc.
SUBSIDIARY VOICEINTEROP, INC. TO BE SPUN OFF IN A FORM 10 AND S-1 REGISTRATION WITH THE SECURITIES AND EXCHANGE COMMISSION BOCA RATON, Fla., April 24, 2018 (GLOBE NEWSWIRE) -- Cleartronic, Inc.,...
CB Scientific’s (CBSC) R & D Focuses on Opioid Crisis, a National Public Health Emergency
October 31, 2017 08:00 ET | CB Scientific Inc
Denver, CO, Oct. 31, 2017 (GLOBE NEWSWIRE) -- CB Scientific, Inc. (OTC PINK: CBSC), a designer, developer and manufacturer of Cannabis Analytical Tools and Devices, Cannabis Medical Delivery Systems...
SPR Therapeutics LOGO 361 TM.jpg
SPR Therapeutics® Secures $25 Million in Series C Financing
September 12, 2017 08:03 ET | SPR Therapeutics, LLC
CLEVELAND, Sept. 12, 2017 (GLOBE NEWSWIRE) -- SPR Therapeutics, Inc., (SPR) a private medical device company that has developed a novel neurostimulation technology for chronic and acute pain,...
SPR Therapeutics LOGO 361 TM.jpg
SPR Therapeutics Promotes Dr. Joseph Boggs to SVP of Research and Development
September 07, 2017 09:13 ET | SPR Therapeutics, LLC
CLEVELAND, Sept. 07, 2017 (GLOBE NEWSWIRE) -- SPR® Therapeutics, LLC (SPR), a private medical device company that has developed a novel, evidence-based neurostimulation platform for chronic and...
SPR Therapeutics LOGO 361 TM.jpg
SPR Therapeutics Awarded $6M Contract From the United States Department of Defense to Advance Non-Opioid Pain Relief Therapy
May 15, 2017 09:03 ET | SPR Therapeutics, LLC
CLEVELAND, May 15, 2017 (GLOBE NEWSWIRE) -- SPR Therapeutics (SPR) has been awarded a $6M four-year contract from the U.S. Department of Defense (DoD) to further advance its SPRINT™ Peripheral Nerve...